CD163 is a macrophage-specific protein hemoglobin specific for M2-tumor-associated macrophages (69), found at increased levels in stages III–IV, compared to stages I–II of CRC, and considered to be involved in immune suppression (70). This evidence concerns the gene CD163 and neoplasm.